Recurrent atrial fibrillation with fast ventricular rate in an elderly lady: old records reveal cause of the malady
DOI:
https://doi.org/10.18203/2320-6012.ijrms20250270Keywords:
AIT, Amiodarone, Thyrotoxicosis, Atrial fibrillationAbstract
Amiodarone is an iodinated benzofuran derivative and is prescribed widely in management of arrythmias- ventricular and supraventricular alike. Excellent efficacy, minimal negative inotropic activity and less rate of ventricular pro arrhythmia makes it the choice of drug in heart failure. Side effects however, make it a drug to be used with caution and they range from pulmonary toxicity to thyroid dysfunction. 15-20% of patients treated with amiodarone are believed to develop some thyroid dysfunction. It can cause amiodarone induced hypothyroidism (AIH) or amiodarone induced thyrotoxicosis (AIT). AIT usually is seen in areas with low uptake of iodine and AIH in areas with sufficient iodine uptake. We report a case of 58-year-old lady with rheumatic heart disease who was started on amiodarone for atrial fibrillation and later presented with recurrent atrial fibrillation (AF) with fast ventricular rate (FVR) and diagnosed as AIT. The challenges in diagnosis and management are discussed.
Metrics
References
Thyroid Dysfunction Induced by Amiodarone Therapy: Practice Essentials, Pathophysiology, Epidemiology. Medscape. Available at: https://emedi cine.medscape.com/article/129033-overview?st=fpf &scode=msp&socialSite=google&form=fpf&icd=login_success_gg_match_fpf. Accessed on 28 October 2024.
Somani P. Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodies. J Clin Pharmacol. 1989;29(5):405-12. DOI: https://doi.org/10.1002/j.1552-4604.1989.tb03352.x
Tsadok MA, Jackevicius CA, Rahme E, Essebag V, Eisenberg MJ, Humphries KH, et al. Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations. CMAJ Can Med Assoc J. 2011;183(12):E817-23. DOI: https://doi.org/10.1503/cmaj.101800
Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22(2):240-54. DOI: https://doi.org/10.1210/edrv.22.2.0427
Rajeswaran C, Shelton RJ, Gilbey SG. Management of amiodarone-induced thyrotoxicosis. Swiss Med Wkly. 2003;133(43–44):579-85. DOI: https://doi.org/10.4414/smw.2003.10296
Cardenas GA, Cabral JM, Leslie CA. Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies. Cleve Clin J Med. 2003 J;70(7):624-6. DOI: https://doi.org/10.3949/ccjm.70.7.624
Sudheer Ahamed P, Mathew A. A Case of Amiodarone-Induced Thyrotoxicosis. Sultan Qaboos Univ Med J. 2009;9(3):319-23.
Kurt IH, Yigit T, Karademir BM. Atrial fibrillation due to late amiodarone-induced thyrotoxicosis. Clin Drug Investig. 2008;28(8):527-31. DOI: https://doi.org/10.2165/00044011-200828080-00008
Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, et al. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid Off J Am Thyroid Assoc. 1997;7(4):541-5. DOI: https://doi.org/10.1089/thy.1997.7.541
Eaton SEM, Euinton HA, Newman CM, Weetman AP, Bennet WM. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf). 2002;56(1):33-8. DOI: https://doi.org/10.1046/j.0300-0664.2001.01457.x
Bogazzi F, Martino E, Dell’Unto E, Brogioni S, Cosci C, Aghini-Lombardi F, et al. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. J Endocrinol Invest. 2003;26(7):635-40. DOI: https://doi.org/10.1007/BF03347021
Wang J, Zhang R. Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis. Br J Radiol. 2024;90(1071):20160836. DOI: https://doi.org/10.1259/bjr.20160836
Irimie A, Piciu D. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology. Curr Radiopharm. 2017;10(3):146-54. DOI: https://doi.org/10.2174/1874471010666170816125402
Macchia PE, Feingold KR. Amiodarone Induced Thyrotoxicosis. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al, editors. Endotext. South Dartmouth (MA): MDText.com, Inc. 2000.
Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries. Circulation. 2014;129(15):1568-76. DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.005451
Downloads
Published
How to Cite
Issue
Section
